Skip to content
10-Q

Quarterly Report

Dimension Therapeutics, Inc.

0001564590-17-016255

← back to feed
Filed
Aug 8, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2017 · Aug 1, 2017 25.05M sh
Capex Q2 2017 · Jun 30, 2017 $24K
Capex Q2 2017 · Jun 30, 2016 $4.91M
Cash And Equivalents Q2 2017 · Jun 30, 2017 $25.06M
Cash And Equivalents Q2 2017 · Dec 31, 2016 $30.23M
Cash And Equivalents Q2 2017 · Jun 30, 2016 $104.65M
Cash And Equivalents Q2 2017 · Dec 31, 2015 $127.05M
Stockholders Equity Q2 2017 · Jun 30, 2017 $36.07M
Stockholders Equity Q2 2017 · Dec 31, 2016 $59.94M
Current Liabilities Q2 2017 · Jun 30, 2017 $17M
Current Liabilities Q2 2017 · Dec 31, 2016 $20.64M
Total Liabilities Q2 2017 · Jun 30, 2017 $28.14M
Total Liabilities Q2 2017 · Dec 31, 2016 $33.92M
Current Assets Q2 2017 · Jun 30, 2017 $56.66M
Current Assets Q2 2017 · Dec 31, 2016 $85.32M
Total Assets Q2 2017 · Jun 30, 2017 $64.21M
Total Assets Q2 2017 · Dec 31, 2016 $93.87M
Sga Expense Q2 2017 · Jun 30, 2017 $2.61M
Sga Expense Q2 2017 · Jun 30, 2017 $6.04M
Sga Expense Q2 2017 · Jun 30, 2016 $3.24M
Sga Expense Q2 2017 · Jun 30, 2016 $6.18M
Rd Expense Q2 2017 · Jun 30, 2017 $14.09M
Rd Expense Q2 2017 · Jun 30, 2017 $27.8M
Rd Expense Q2 2017 · Jun 30, 2016 $11.24M
Rd Expense Q2 2017 · Jun 30, 2016 $20.05M
Net Income Q2 2017 · Jun 30, 2017 −$12.31M
Net Income Q2 2017 · Jun 30, 2017 −$25.8M
Net Income Q2 2017 · Jun 30, 2016 −$12.1M
Net Income Q2 2017 · Jun 30, 2016 −$21.61M
Operating Income Q2 2017 · Jun 30, 2017 −$12.33M
Operating Income Q2 2017 · Jun 30, 2017 −$25.86M
Operating Income Q2 2017 · Jun 30, 2016 −$12.11M
Operating Income Q2 2017 · Jun 30, 2016 −$21.65M
Revenue Q2 2017 · Jun 30, 2017 $4.37M
Revenue Q2 2017 · Jun 30, 2017 $7.99M
Revenue Q2 2017 · Jun 30, 2016 $2.37M
Revenue Q2 2017 · Jun 30, 2016 $4.58M